Introduces revolutionary approach to workflow management to enhance operational efficiency and optimize process efficiency
NATCO has decided to price the product at Rs.15, 900 MRP consistent with the company’s stand before the court
Nadda noted that on the basis of economic caste census, 50 crore people were brought under this scheme
Findings likely to generate hypotheses about potential new uses of drugs
Fexuprazan has the longest half-life of 9 hours among potassium-competitive acid blockers
The portfolio includes branded injectable cephalosporines for infectious diseases
The company expects to launch this product through its marketing partner in the near future
The IND application supports the next phase of development of SBO-154
Approval based on AEGEAN Phase III trial results which showed a 32% reduction in the risk of recurrence, progression or death vs. neoadjuvant chemotherapy alone
Subscribe To Our Newsletter & Stay Updated
